Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of IL-II in the Development of Autoimmune Response in Multiple Sclerosis

NCT03735823 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT03735823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03735823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of IL-II in the Development of Autoimmune Response in Multiple Sclerosis
Lead sponsor
Thomas Jefferson University
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2018
Completion date
May 31, 2023
Enrollment
96 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis